Promoting Sleep and Physical Activity Among Adolescent Psychiatric Patients
SLEEPAC
Transdiagnostic Sleep Intervention Combined With Physical Activity Counseling (SLEEPAC) in Adolescent Psychiatric Patients: A Blended Care Approach
1 other identifier
interventional
140
1 country
2
Brief Summary
Mental health disorders pose a significant burden on adolescent populations globally, often accompanied by sleep disturbances. Emerging evidence suggests that addressing sleep issues can improve mental health outcomes, while physical activity is increasingly recognized as beneficial for both sleep and mental well-being. This study aims to assess the effectiveness of a novel intervention (SLEEPAC), combining cognitive-behavioral therapy for insomnia (CBT-I), circadian treatment, and PA counseling, compared to treatment as usual (TAU), in improving psychopathology among adolescent psychiatric outpatients with sleep disturbances. Secondary outcomes include improvements in sleep health, physical activity levels, cognitive performance and self-esteem. Additionally, the study seeks to explore the predictive value of sleep neurophysiological biomarkers using high-density sleep electroencephalography (EEG), contributing to advancements in precision psychiatry for this population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2024
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 30, 2024
CompletedFirst Posted
Study publicly available on registry
May 9, 2024
CompletedStudy Start
First participant enrolled
June 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
May 9, 2024
May 1, 2024
2 years
April 30, 2024
May 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Psychopathology
Symptom Checklist-90-Revised (SCL-90-R) is one of the most comprehensive and widely used questionnaires to assess psychopathology. It is validated for youth psychiatric inpatients from age 13 onwards. The Symptom Checklist contains a list of problems and complaints that people sometimes have. Participants are asked how much they were bothered by that problem during the past week. Answers range from 0=not at all to 4=extremely. Thus, a higher factor score indicated more serious psychiatric symptoms problems.
10 minutes
Secondary Outcomes (4)
Composite Sleep Health
10-20 min (questionnaire), 7 days (sleep tracker Oura Gen3)
Physical Activity
7 days
Cognitive performance
10 min
Self-esteem
5 min
Study Arms (2)
SLEEPAC
EXPERIMENTALIn addition to treatment-as-usual (TAU), participants of the SLEEPAC arm will receive a multi-component sleep intervention combining elements of CBT-i, circadian adaptation, and physical activity counselling.
Control
NO INTERVENTIONParticipants of the control group continue with their treatment as usual
Interventions
6x individual blended-care counselling sessions: * 1 x face-to-face kick-off sessions at study site (45 min) * 1 x try-out exercise sessions at study site (45 min) * 4 x online face-to-face sessions via zoom (30 min) * Both the intervention and the waitlist control condition will continue with TAU. Component 1: CBT-I: Sleep restriction, and cognitive therapy strategies with education about sleep-wake regulation, sleep hygiene, and pre-bedtime counter arousal methods. Component 2: Circadian treatment: Morning bright light therapy with a gradual advanced sleep schedule and timed morning exercise. Component 3: Physical activity counselling involves providing personalized guidance and support to individuals to help them adopt and maintain a physically active lifestyle tailored to their preferences and needs.
Eligibility Criteria
You may qualify if:
- Aged between 13 to 18 years
- Presence of insomnia and/or delayed sleep-wake phase disorder
- At least one further diagnosis of DSM-5
- Written informed consent of parents / primary caregiver
You may not qualify if:
- Organic sleep- and brain disorders (i.e., obstructive sleep apnea, narcolepsy, epilepsy)
- Suffering from medical conditions, which prevent participation in physical activity
- Changes to medication regime during the study protocol
- Color-blindness (due to stroop test)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Christin Langlead
- Department of Sport, Exercise, and Health, University of Baselcollaborator
- University Hospital of Child and Adolescent Psychiatry and Psychotherapycollaborator
- University Children's Hospital of Baselcollaborator
- Psychiatry Basellandcollaborator
Study Sites (2)
Department of Sport, Exercise, and Health, University of Basel
Basel, Canton of Basel-City, 4052, Switzerland
University Hospital of Child and Adolescent Psychiatry and Psychotherapy
Bern, Canton of Bern, 3000, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD
Study Record Dates
First Submitted
April 30, 2024
First Posted
May 9, 2024
Study Start
June 1, 2024
Primary Completion (Estimated)
May 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
May 9, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share